A comparative study of Ayurvedic medicine and modern medicine treatment in Medoroga (overweight)

Sandesh Goje; Vaishali Kuchewar; Shweta Parwe; Nitin Biswas

doi:10.53730/ijhs.v6nS1.5012

Authors

Sandesh Goje Ph.D Scholar Kayachikisa Department, Mahatma Gandhi Ayurved college Hospital & Research Center, Salod (H),Datta Meghe Institute of Medical Sciences, Nagpur
Vaishali Kuchewar Dean, Professor, Department of Kayachikitsa, Mahatma Gandhi Ayurved college Hospital & Research Centre, Salod (H), Datta Meghe Institute of Medical Sciences, Nagpur
Shweta Parwe Professor, Department of Panchakarma, Mahatma Gandhi Ayurved college Hospital & Research Centre, Salod (H), Datta Meghe Institute of Medical Sciences, Nagpur
Nitin Biswas

Keywords:

Jayantyadi churna, Medoroga, Overweight, Modern treatment

Abstract

Medoroga (obesity) is one of the most important risk factors for the development of hyperlipidemia, atherosclerosis, cardiovascular disease, renal disease etc. and the leading cause of death. To compare the efficacy as Ayurvedic medicine and Modern medicine treatment modality on BMI, BMR, Waist Circumference & lipid profile in Overweight (Medoroga). Newly diagnosed Medoroga (Overweight) patients will be selected and divided into two groups. In both groups, dietary, physical therapy, and behavioral therapy will be recommended. According to modern medicine, it is the treatment protocol of overweight. Ayurveda also included pathyaahar, vyayam and satvavjay in the treatment principle of Medoroga. In group A, Jayantyadi churna is given in a dose of 3grams twice a day before meal for 180 days and as no medicine is advised in modern medicine for overweight, placebo will be given for 180 days. Follow up were performed on 0, 30^th, 60^th, 90^th, 120^th, 150^th and 180^th. Our hypothesis is that Group A can be found to be more effective than Group B due to Jayantyadi churna which acts on Medodhatvagni, BMI,BMR, waist circumference and lipid profile.

Downloads

Download data is not yet available.

References

Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health. 2009 Mar 25;9:88. doi: 10.1186/1471-2458-9-88. PMID: 19320986; PMCID: PMC2667420.

Verma A, Shete SU, Doddoli G. An integrated therapy approach for the management ofobesity-associated disorders: A case report. J Family Med Prim Care [serial online] 2019 [cited 2020 Feb 23]; 8:1491-4.

Vennu V, Abdulrahman TA, Bindawas SM. The Prevalence of Overweight, Obesity, Hypertension, and Diabetes in India: Analysis of the 2015-2016 National Family Health Survey. Int J Environ Res Public Health. 2019 Oct 18;16(20):3987. doi: 10.3390/ijerph16203987. PMID: 31635366; PMCID: PMC6843936.

Luhar, Shammi et al. “Trends in the socioeconomic patterning of overweight/obesity in India: a repeated cross-sectional study using nationally representative data.” BMJ open vol. 8,10 e023935. 21 Oct. 2018, doi:10.1136/bmjopen-2018-023935.

Deogade M S, KSR Prasad, Nilima W, Vibration therapy a Conventional Massage influences on Sthoulya (Obesity): J-ISM, V2 N2, Apr-June 2014; pp.63- 65.

Duncan MJ, Brown WJ, Burrows TL, Collins CE, Fenton S, Glozier N, Kolt GS, Morgan PJ, Hensley M, Holliday EG, Murawski B, Plotnikoff RC, Rayward AT, Stamatakis E, Vandelanotte C. Examining the efficacy of a multicomponent m-Health physical activity, diet and sleep intervention for weight loss in overweight and obese adults: randomised controlled trial protocol. BMJ Open. 2018 Oct 30;8(10):e026179. doi: 10.1136/bmjopen-2018-026179. PMID: 30381313; PMCID: PMC6224765.

National Institute of Health (NIH). The Practical Guide to the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. National Heart Lung and Blood Institute Guidelines. 2000:1-94.

Tchang BG, Kumar RB, Aronne LJ. Pharmacologic Treatment of Overweight and Obesity in Adults. [Updated 2020 Oct 7]. In: Feingold KR, Anawalt B, Boyce A, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK279038/

Shashtri . S., Madhavanidana Part 2, Overweight (Medoroga) nidanamadhyaya no. 34/1, chaukhambharPrakashan Varanasi, reprint 2010, p.no. 34

Acharya Shree radhakrushnaParashar, SharangadharSamhita, PurvakhandaRogaGananaPrakaranAdhyaya, 7/64-65, 2012, BaidyanathayurvedbhawanPvt. Ltd. Nagpur, edition 2012, p.g no. 143

Sharma P. S. CharakaSamhita, Sutrasthana, ShadvirechanshatashritiyaAdhyaya, 4/3, edited by JadavajiTrikamjiAchrya, 5 th ed. ChaukhambhaSurbhartiPrakashan , Varanasi, reprint 2014; p. 76-77

Sharma P. S. CharakaSamhita, Sutrasthana, AshtoninditiyaAdhyaya, 21/3-9, edited by JadavajiTrikamjiAchrya, 5 th ed. ChaukhambhaSurbhartiPrakashan , Varanasi, reprint 2014; p. 398-401

Pandey D.Basvarajiyam, AshtadashamAdhyaya,,ChaukhambhaKrushnadas Academy Varanasi, edition 1st, reprint 2010; p. 539 – 543.

National Institute of Health (NIH). The Practical Guide to the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. National Heart Lung and Blood Institute Guidelines. 2000:1-94.

Bond Brill J, Perry AC, Parker L, Robinson A, Burnett K. Dose-response effect of walking exercise on weight loss. How much is enough? Int J ObesRelatMetabDisord. 2002 Nov;26(11):1484-93. doi: 10.1038/sj.ijo.0802133. PMID: 12439651.

Margaret-Mary G Wilson, Thomas D. et al, Appetite assessment: simple appetite Questionnaire predicts weight loss in community-dwelling adults and nursing home residents,The American Journal of Clinical Nutrition, Volume 82, Issue 5, November 2005, Pages 1074–1081, https://doi.org/10.1093/ajcn/82.5.1074.

Parwe Shweta D. Effect of Gomutra Niruha Basti on Sthaulya (obesity).

Parwe S, Nisargandha M., Bhagwat P., Study the effect of Rodhradi Gana Basti and Udvartana in Sthaulya (Obesity): A Study Protocol, International Journal of Botany Studies, 2020 Oct. 5;5: 519-522.,www.botanyjournals.com

Kumari H, Pushpan R, Nishteswar K. Medohara and Lekhaniya dravyas (anti-obesity and hypolipidemic drugs) in Ayurvedic classics: A critical review. Ayu. 2013 Jan;34(1):11-6. doi: 10.4103/0974-8520.115437. PMID: 24049399; PMCID: PMC3764867.

S., Sarada & E., Padmini. (2018). Effect of Terminalia chebula and Gallic Acid on Increased Adiposity of High-Fat Diet Induced Hyperlipidemic Mice. International Journal of Current Research and Review. 10. 46-52. 10.31782/IJCRR.2018.10107.

Goyal R, Kaur M, Chandola HM. A clinical study on the role of Agnimanthadi compound in the management of Sthaulya (obesity). Ayu. 2011 Apr;32(2):241-9. doi: 10.4103/0974-8520.92553. PMID: 22408310; PMCID: PMC3296348.

M. B. Kavita, Mallika KJ, Poornima B. A clinical study on effect of amalaki (Indian gooseberry) as food supplement in dyslipidemia. Int. J. Res. Ayurveda Pharm. Jul – Aug2016;7(4):59-64 http://dx.doi.org/10.7897/2277-4343.074134

Pal, Ombeer & Nayak, Shraddha & Gupta, Rajkumar. (2020). Preliminary Clinical Study Of Kutaja (HOLARRHENA ANTIDYSENTERICA LINN. (BARK AND SEED) On Medodushti W.S.R To Hyperlipidemia. 8. 1242-1247. 10.20959/wjpr201913-16319.

Rasheed, Aamil, Sourya Acharya, Samarth Shukla, Sunil Kumar, Roopesh Yarappa, Yash Gupte, and Vidyashree Hulkoti. “High-Sensitivity C-Reactive Protein in Metabolic Healthy Obesity (MHO).” Journal Of Evolution Of Medical And Dental Sciences-Jemds 9, no. 7 (February 17, 2020): 443–47. https://doi.org/10.14260/jemds/2020/100.

Garg, Mayank, and Sandip Mohale. “Prevalence of Metabolic Obesity Normal Weight (MONW) in Cardiovascular Disease Patients - A Hospital-Based Case Control Study.” Journal Of Evolution Of Medical And Dental Sciences-Jemds 9, no. 34 (August 24, 2020): 2427–31. https://doi.org/10.14260/jemds/2020/528.

Hulkoti, Vidyashree S., Sourya Acharya, Samarth Shukla, Sree Karthik Partapa, and Yash Gupte. “In Search of an Ideal Obesity Assessment Tool : Is Body Mass Index Reliable Enough?” Journal Of Evolution Of Medical And Dental Sciences-Jemds 9, no. 35 (August 31, 2020): 2556–60. https://doi.org/10.14260/jemds/2020/555.

Ghia, Canna Jagdish, Archana Sushil Panda, Linesh R. Khobragade, Rajesh Kumar Jha, and Gautam S. Rambhad. “Alternate Day versus Once Daily Atorvastatin for Primary Prevention of (CHD) in Naive Patients of Dyslipidemia.” Journal Of Clinical And Diagnostic Research 8, no. 3 (March 2014): 27–31. https://doi.org/10.7860/JCDR/2014/7359.4096.

Wajpeyi, Sadhana Misar. “Analysis of Etiological Factors of Dyslipidemia -A Case Control Study.” International Journal Of Ayurvedic Medicine 11, no. 1 (March 2020): 92–97.

Kakade, Tejas Laxman, and Sadhana Misar Wajpeyi. “Study in the Effect of Yavavati in the Management of Dyslipidemia.” International Journal Of Ayurvedic Medicine 11, no. 2 (June 2020): 265–70.